Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jay D. Kranzler currently holds 30,000 shares of AVENUE THERAPEUTICS, INC. (ATXI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jay D. Kranzler has been a net seller of ATXI stock. They have purchased $0 and sold $5.5M worth of shares.
Jay D. Kranzler's most recent insider trade was on Sep 23, 2024, when they sold 30,000 shares at $0.00 per share.
Jay D. Kranzler serves as Executive at AVENUE THERAPEUTICS, INC. (ATXI). They have executed 408 insider transactions totaling $5.5M over their tenure at the company.
Jay D. Kranzler holds the position of Executive at AVENUE THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Jay D. Kranzler has shown a selling trading pattern, with $0 in total purchases and $5.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jay D. Kranzler was on Dec 23, 2010, when they sold $983.4K worth of CYPB shares. This transaction involved 152,464 shares at $6.45 per share.
Jay D. Kranzler currently owns 30,000 shares of AVENUE THERAPEUTICS, INC. (ATXI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jay D. Kranzler's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jay D. Kranzler has 408 Form 4 filings on record as an insider at AVENUE THERAPEUTICS, INC..
Set alerts for Jay D. Kranzler and 40,000+ other insiders.